SFB1530.DE

Last Updated: July 06, 2024

SFB1530.DE Summary

sfb1530.de has 3 NS records, 1 A records, 0 AAAA records, 4 MX records, and 0 TXT records. Name servers for sfb1530.de are ns1.domaindiscount24.net, ns3.domaindiscount24.net, ns2.domaindiscount24.net. A records for sfb1530.de are 188.94.254.222. MX records that process @sfb1530.de email are mx4.agenturserver.de, mx3.agenturserver.de, mx2.agenturserver.de, mx1.agenturserver.de. We have observed sfb1530.de to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. The domain's primary website is hosted on a Apache web server at 188.94.254.222 in Germany. The website's description is: "the crc / sfb 1530 is a network of internationally visible investigators with exceptional expertise in innovative lymphoma models, cutting-edge genomics and proteomics platforms, comprehensively characterized, large cohorts of lymphoma patients, powerful bioinformatics and a successful clinical trial infrastructure working, with the goal to significantly increase therapeutic responses and cure rates of high-risk b cell malignancies."

Search DigitalStakeout ASI to find another asset.

SFB1530.DE DNS Records

A Records

188.94.254.222

AAAA Records

No DNS AAAA records

TXT Records

No DNS TXT records

Search DigitalStakeout ASI to find another asset.

SFB1530.DE Subdomains

sfb1530.de has 2 subdomains in our inventory.

Hostname IP Address
www.sfb1530.de 188.94.254.222
sfb1530.de 188.94.254.222

Search DigitalStakeout ASI to find another asset.

SFB1530.DE Website

Web Server

Apache

IP Address

188.94.254.222

Country

Germany

Meta Tags

og:title: sfb 1530 | elucidation and targeting of pathogenic mechanisms in b cell malignancies

og:description: the crc / sfb 1530 is a network of internationally visible investigators with exceptional expertise in innovative lymphoma models, cutting-edge genomics and proteomics platforms, comprehensively characterized, large cohorts of lymphoma patients, powerful bioinformatics and a successful clinical trial infrastructure working, with the goal to significantly increase therapeutic responses and cure rates of high-risk b cell malignancies.

Search DigitalStakeout ASI to find another asset.

SFB1530.DE Certificate Trust

No certificate log entry found for sfb1530.de. Please check back at a later time.

Search DigitalStakeout ASI to find another asset.